chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt became very lightheaded and dizzy after receiving covid vaccine. Pt vomited x1 in (ems) tent. vitals as noted. Pt hx of HTN, no allergies. ot right later recumbent with water, states she feels much better. Pt observed with vitals. Pt is alert to people, place and time. Daughter is with pt and is driver Pt denies eating before vaccine. . Pt able to sit with out incident- again states that she feel much better. skin is normal. pt refusing transport at this time.  bp 91/57 p 83 r 14 09:37 114/69 p 73 r 14 09:46 135/81 p 77 r 14
This child had his last set of immunizations on 3-31-08.  He did not have any reactions.  He died of SIDS on 4-24-08.  6/13 Autopsy report states COD as sudden unexplained death in infancy.  Report also states patient had petechiae of thymus & visceral surfaces of lungs; no evidence of injury; normal growth parameters; neg metabolic screen; no evidence of aspiration.  Had been placed in crib on back w/propped bottle.  Found unresponsive.
Pt developed a sore throat and then epiglottis, no signs of an abscess.
patient got light headed, dizzy, placed on ground elevated feet gave fluids and a salty snack, observed for additional 15 minutes
Dark urine; Confusion/dizziness; Headache; Tingling of the ear; Flu Like Symptoms; Body Aches; Locked Jaw; Confusion/Dizziness; This spontaneous case was reported by a pharmacist and describes the occurrence of CONFUSIONAL STATE (Confusion/dizziness) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     The patient's past medical history included Neurological disorder NOS, Tingling and Panic attacks.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CONFUSIONAL STATE (Confusion/dizziness). At the time of the report, CONFUSIONAL STATE (Confusion/dizziness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication not provided. Concomitant medication not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: No new information received; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sick; Stomach upset; Bodyaches; Fever; Nauseated; Episodes of vomiting; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Sick), ABDOMINAL DISCOMFORT (Stomach upset), MYALGIA (Bodyaches), PYREXIA (Fever) and NAUSEA (Nauseated) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced ILLNESS (Sick), ABDOMINAL DISCOMFORT (Stomach upset), MYALGIA (Bodyaches), PYREXIA (Fever), NAUSEA (Nauseated) and VOMITING (Episodes of vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Mar-2021, ILLNESS (Sick), ABDOMINAL DISCOMFORT (Stomach upset), MYALGIA (Bodyaches), PYREXIA (Fever), NAUSEA (Nauseated) and VOMITING (Episodes of vomiting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
blisters all over his entire body. which are painful.; blisters all over his entire body. which are painful.; This case was reported by a consumer and described the occurrence of blister in a 68-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash (received 1st dose in september 2020, refer case US2020244427).   In November 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced blister and pain. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the blister and pain were unknown.   It was unknown if the reporter considered the blister and pain to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix and breaking out in blisters all over entire body which are painful.  The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020244427:same reporter
called  Dr and emailed , fever, chills, tiredness, chest congestion, wheezing, tightness and throat closing unable to breathe. fever and chills went a way after a week , tightness in throat over 6 weeks and constant coughing , high blood pressure. ' had a physical one week prior or the shot and blood pressure was perfect' never had high blood pressure before the shot
Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received RSVPreF3 adjuvanted (RSV vaccine) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE for prophylaxis.   On 14-SEP-2023, the patient received RSV vaccine and INFLUENZA VACCINE. In SEP-2023, an unknown time after receiving RSV vaccine, the patient experienced pain in arm (Verbatim: Sore arm).The outcome of the pain in arm was not reported.   It was unknown if the reporter considered the pain in arm to be related to RSV vaccine.     It was unknown if the company considered the pain in arm to be related to RSV vaccine.   Additional Information: GSK Receipt date: 15-SEP-2023 and 18-SEP-2023 This case was reported by patient via interactive digital media. The patient reported that he or she got the RSV and the flu shot together yesterday.  No side effects just a really sore arm. It was unknown if the company considered the pain in arm to be related to Flu vaccine.  Follow up was not possible, as no contact, details were available.
On 4/15 - patient presented with dull ache/pain behind right knee and sought medical treatment to address and diagnose possible issues.
09/26 I was exposed to a COVID patient. On September 29, 2022, I started having a head cold. On Sept 30, I had overall fatigue. I tested positive on a home test on 10/1/2022 and I went to a minute clinic and received PAXLOVID. I recovered in 3 days.
It has been 11 days since my first vaccine. I can not move my arm to the side or back. I have been to the urgent care and yesterday followed up. My upper arm is swollen.My. Primary at this appointment told me that due to the shot I now have tendinitis in my shoulder and there is inflammation in my upper arm. They gave me a prescription for stronger ibuprofen and told me that if it wasn?t better in a few days I would have to go to Orthopaedic.
RASH TX WITH BENADRYL PROGRESSIVE WORSE. SEEN FACILITY DX ERYTHEMA MULTIFORME, UNSPECIFIED.
Left arm pain immediately after injection which worsened over time.  I thought a nerve had been hit so I kept ignoring it. The pain just kept intensifying it was unbearable.  I went to the ER while on vacation and I was having a heart attack. Never chest pain.  all arm pain. I had to have a stent placed and wait to be seen by a cardiologist at home to follow my care.  My cardiologist is who told me to report this
The same evening of when I received the shot, approximately 6 hrs after, I started to hear ringing in my left ear. It is now 17 days after my symptoms first appeared, and it has not gone away or gotten any better.
Still has slight pain (L) upper arm and shoulder intermittently (at site and in joint).
The patient was given 0.3 ml of undiluted Pfizer Covid vaccine, resulting in 6 times the authorized dose.  The error was discovered by myself about 1 hour after vaccine administration and the patient was contacted via phone about 3 hours after administration.  I advised the patient to take 2 extra strength Tylenol before bed and upon awakening the next morning to help with possible adverse effects from the vaccine.  The patient was called the following morning and reports no adverse effects.
This case was reported by a physician and described the occurrence of not responding to therapy in a 52-year-old male subject who was vaccinated with Engerix B for prophylaxis.  There were no concurrent medications or relevant medical history.  On unspecified dates, the subject received a series of three doses (1st, 2nd, and 3rd doses) of Engerix B (unknown).  At an unspecified time after vaccination with the series of three doses of Engerix B, the subject experienced not responding to therapy.  At the time of reporting, the event was unresolved.
Patient reports swelling of head and hives on trunk and extremities beginning on 01/15/22. Patient sought treatment on 01/16/22 and was prescribed a Medrol Dose Pack. Patient reported AE to pharmacist on 01/17/22.
Injection in R upper thigh on 4/24/06. Swelling at site by that PM. Less today.
Sever headache and feeling of inside of scull on fire - lasted 3 hr and lifted. Went to ER.
NONE COVID-19 EXPIRED 11/22/2022 GIVEN 2/10/2023
SEVERE BODY PAIN; BUMP AT INJECTION SITE; BURNING SENSATION IN ARM; FEELING COLD INSIDE BODY; CHILLS; NAUSEA; MUSCLE PAIN; HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported.  On 05-APR-2021, the subject experienced bump at injection site. On 05-APR-2021, the subject experienced burning sensation in arm. On 05-APR-2021, the subject experienced feeling cold inside body. On 05-APR-2021, the subject experienced chills. On 05-APR-2021, the subject experienced nausea. On 05-APR-2021, the subject experienced muscle pain. On 05-APR-2021, the subject experienced headache. On 05-APR-2021 23:30, the subject experienced severe body pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe body pain, burning sensation in arm, and muscle pain on APR-2021, and had not recovered from nausea, chills, feeling cold inside body, bump at injection site, and headache. This report was non-serious.
This spontaneous report was received from a physician via company representatives referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On 03-NOV-2014, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 0.5 mL (Lot # K007822, expiration date 15-AUG-2015) single dose, route and anatomical location were not provided. There was no concomitant medication provided. No adverse effects were reported. On an unknown date, the PNEUMOVAX had a temperature excursion for 40 and 72 hours, the lowest recorded temperature was 28F and the highest was 47F. The vaccine status was reported as "in excursion", the storage criteria and the vaccine excursion were reported as "Refrigerator (R)". There was no product quality complaint involved. This is one of several cases received from the same reporter. Additional information has been requested.
Chills, arthralgia, myalgia for 12-16 hours, onset 12 hours post vaccine. Very large (3x4 inch) area of redness, induration, and erythema surrounding injection site 60 hours post injection.
Seen in office for 15 mo WCE on 9/30/15 and rec'd immunizations. Returned on 10/05/15 with dad who reported "knot in lt thigh" following imm. Also reported pt with vomiting and blue lips x 2 days. Dx with URI. (LT) thigh with 2 cm x 2cm firm nodule; no edema, redness, induration; afebrile. No tx.
a little redness/red skin; tenderness; irritation; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): 2022NVX-US-000004045.  A male patient received BNT162b2 (BNT162B2), on 20Mar2022 as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (Dose: 01), administration date: 26Feb2022, for COVID-19 Immunization, reaction(s): "irritation", "a little redness", "tenderness". The following information was reported: ERYTHEMA (non-serious) with onset 2022, outcome "unknown", described as "a little redness/red skin"; SKIN IRRITATION (non-serious) with onset 2022, outcome "unknown", described as "irritation"; TENDERNESS (non-serious) with onset 2022, outcome "unknown".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
17OCT91 pt recvd dose of Engerix-B & nothing happened; 14NOV91 recvd Engerix-B & less htan 24 hrs p/vax pt felt burning, numbness which radiated to arms, toes & head; then devel h/a; c/o did not feel well; rxn still persists;
About 5 hours after getting the Flu shot, her face became red and her face and eyes were swollen ("she looked like she had been crying"). She felt dizzy but did not vomit. She also developed a large wheel that was tender at the injection site.  Mom gave her Ibuprofen and then a few hours later the symptoms gradually subsided. She had never had a reaction to the vaccine before. No hx of egg allergy.
Burning rash on T6 dermatome began 4/13. Diagnosed as shingles 4/16. Seven days of 1000mg Valacyclovir 3x a day.
Chills thru night, better next am,  the started running temp, then chills, muscle pain, sluggish feeling began again and lasted until around midnight
dr unsure since 2nd vaccine dealing with chronic. It started out as just a rash on that arm about 24 to 48 hours. It never went away though. It came and went until it came to a head in August. At that point the hives had spread all over and my eyes swelled shut. At that point I was placed on a 7 day dose of prednisone and advised to take Benadryl and allergy meds as needed. They would come and go and never get better so I made the  appointment with Dr. who is an allergist. We started to try to find out what could have caused the response. He started me on 2 Allegra a day, Singulair and Pepcid for about a month and that was not effective so he added the Xolair injections once a month. That seems to be getting it under control. If I miss any doses of the medicine the hives or rashes return. I still have many outbreaks but I can tell it improving as I am not embarrassed to go outside. I am still in treatment.
Large bruise, larger than silver dollar, now fading 10/7/03. Hard lump in center size of a dime. Swelling and pain. Arm still sore (10/7/03). Took Tylenol.
I received the shot on Tuesday afternoon. I had a stronger reaction to it than to other vaccines (Flu, pneumonia) --  felt achey, tired, but took ibuprofen that night and an Aleve on Wednesday. It was too sore to sleep on that side both Tuesday and Wednesday nights, but it wasn't until thursday morning that I realized the soreness was beyond the injection site, and saw in the mirror that there was a red, slightly inflamed, spot on my arm about 3 inches wide and 6 inches long. It was hot and sore to the touch. I went to the local urgent care clinic. They were puzzled by the reaction, but diagnosed cellulitis and gave me a prescription for Cephalexin (500 mg, 3Xday) and told me to discuss it with my regular physician and report it to the CDC. I see my regular doctor next Tuesday and will discuss it with her.  Just started the antibiotics, so don't know if they will clear it not. I am not sure when this started, but given the size of the patch on my arm, I would guess it started as soon as I got the injection.
pt recv vax; 5 hr later, mom reported thigh to be red & swollen; T 101.4; Tempra & cool compresses; redness gone next day but still swollen & fever;
Patient called 12/16/2020. Patient said she got the flu shot on 11/23/2020 and had pain at injection site and shoulder pain and less range of motion in     left shoulder.
Pt diagnosed as ADES [Acute Demyelinating Encephalitis syndrome]. Currently in hospital.
7/25/13 700 am 1 in diameter around injection site, redness, swelling, pain and warmth. 7/26/13 am 2" diameter around site red, swollen, warm, increased pain iced 6 x 20 min that day. No fever 7/27/13 am area increased to 2" (ht) x 23" (width), More painful, increased redness, swollen and hot to touch, iced 10 x for 20 min each. Sluggish, no fever 7/28/13 Size 2" x 2" was still red, swollen, warm and was painful. No fever. By 7/29/13 am, ara was 1 in by 1 in. Was much less swollen, red, and had very little pain. I iced the area four times that day. No fever. 7/30/13-8/04/13 injection site was sore, sensitive, and achy. No redness or warmth. No fever. 8/05/13 injection site feels normal.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. The reporter stated that on an unknown date, an unspecified number of patients may have been administered GARDASIL that was exposed to an unsupported temperature excursion (30 degrees Fahrenheit for 2 hours), (lot number and expiration date unknown), dose, route, anatomical location and dose number unspecified for an unknown indication. No adverse effect was reported. Additional information has been requested.
headache, stiffnes of neck, fever 102, suspecting viral meningitis, pneumonia.  11/21/08 MR received for DOS 11/12-17/2008 with dx:Viral meningitis vs influenza vaccination reaction.  Bilateral pneumonia.  Elevated LFTs. L maxillary sinusitis.  Headache.  Hypoxia.  Pt presented with myalgias, aches, stiff neck, fever, chills, poor appetite, lassitude, one episode of vomiting and worsening H/A.  Seen by PCP earlier, tx with IVF with worsening of sx.  Concern for viral meningitis and admitted for observation. Neuro consult with impression: Viral illness with mild meningeal involvement, now with severe pulmonary involvement with late onset. Pt developed shortness of breath. Dx with pneumonia. ID consult with Impression:  Viral syndrome, Post fraction complication of influenza vaccination, Bilateral pneumonia, Headache. Tx with abx and Tamiflu. Pt still with c/o h/a, but improving. Pt will f/u elevated transaminases as outpt.
Headaches all the time for a week and then most of the time after. Tiredness for a week muscle aches for a week sore arm for a little over a week Nausea intermittantly
Armpit lymph nodes swelled up for about a week and a half.  Along with the usual nausea and sluggishness of the the vaccine.
DVT bloodclot in leg.  Then clots in my lungs.  4 day hospitalization.   Released and still on blood thinners.
This spontaneous report as received from a registered medical assistant refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions or concomitant medication was reported. In June 2015, the patient was vaccinated with the first dose of GARDASIL 0.5 ml, intramuscularly (lot # and expiry date were not specified). On 15-NOV-2015, the patient received the second dose of GARDASIL 0.5 ml, intramuscularly (lot # and expiry date were not specified). On 15-DEC-2015, the patient was vaccinated with the third dose of GARDASIL 0.5 ml, intramuscularly (lot # and expiry date were not specified). No adverse effects were reported. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 52-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Lot number: 330308D), in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), as dose 2, single (Lot number: 048B21A), in left arm and as dose 3 (booster), single (Lot number: 081B21A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Just overweight and over 50" (unspecified if ongoing), notes: Just overweight and over 50. Patient had no known allergies. There were no concomitant medications, also reported as no other medication in 2weeks. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 11May2022, outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (11May2022) Positive, notes: Took Paxlovid on my first day of COVID test; (20May2022) Negative, notes: Tested negative on day 9; (23May2022) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 Paxlovid (start date: 11May2022, stop date: 15May2022). Clinical course was reported as, patient took Paxlovid on first day of COVID test and symptoms, and tested negative on day 9 and felt fine. On day 11, 21May2022 at 12:00 started feeling like a had a head cold, and tired, today (at the time of report) patient tested and she was positive again. Patient was recovering from symptoms and no treatment received for symptoms.
"Pain from the jab"; Could barely get out of bed; Barely had energy.; Arm was sore; Slept a lot; Very sharp pain on side of her head; Chills, fever, got into bed and was shivering; Chills, fever, got into bed and was shivering; This spontaneous case was reported by a consumer and describes the occurrence of PAIN ("Pain from the jab"), MALAISE (Could barely get out of bed), ASTHENIA (Barely had energy.), PAIN IN EXTREMITY (Arm was sore) and HYPERSOMNIA (Slept a lot) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COPD. Concurrent medical conditions included Hypertension, Hypothyroidism and Drug allergy (Thorazine and Compazine).    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN ("Pain from the jab"), MALAISE (Could barely get out of bed), ASTHENIA (Barely had energy.), PAIN IN EXTREMITY (Arm was sore), HYPERSOMNIA (Slept a lot), HEADACHE (Very sharp pain on side of her head), CHILLS (Chills, fever, got into bed and was shivering) and PYREXIA (Chills, fever, got into bed and was shivering). At the time of the report, PAIN ("Pain from the jab"), MALAISE (Could barely get out of bed), ASTHENIA (Barely had energy.), PAIN IN EXTREMITY (Arm was sore), HYPERSOMNIA (Slept a lot), HEADACHE (Very sharp pain on side of her head), CHILLS (Chills, fever, got into bed and was shivering) and PYREXIA (Chills, fever, got into bed and was shivering) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was reported by the reporter.  No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Follow up received included: reporter contact details
Systemic: Abdominal Pain-Severe, Additional Details: Patient came and received the second dose of Pfizer vaccine on may 27th. Tried to contact patient to make sure she is feeling good after the second dose but no response
ONSET OF GILLIAN BARRE SYNDROME; MUSCLE WEAKNESS OVER A PERIOD OF 7 DAYS UNTIL COMPLETE PARALYSIS
Patient was in the office for second primary series of Pfizer vaccine but was given bivalent booster instead.
Received injection in left arm and woke up the next morning with swelling and rash in the bend of the right arm and face.
Erythema, induration, tenderness. Sulfamethoxazole-Trimethoprim 9ML po Bid x 10 days. Warm compress.